Kelsy Reisch
Nurse Practitioner · Dallas, TXNPI 1063012508
Payments from drug & device makers
Across 277 payments — averaging $20.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$719
- AbbVie$623
- Novo Nordisk$501
- Johnson & Johnson$489
- Boehringer Ingelheim$357
- Gilead$340
- plus $3K from 31 others
What the payments were for
- Food & beverage$5,66999%
- Education$451%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 37 | $719 |
| AbbVie | 34 | $623 |
| Novo Nordisk | 32 | $501 |
| Johnson & Johnson | 17 | $489 |
| Boehringer Ingelheim | 16 | $357 |
| Gilead | 17 | $340 |
| GSK | 15 | $286 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $241 |
| Merck | 11 | $211 |
| Amgen | 10 | $196 |
| AstraZeneca | 5 | $173 |
| Supernus Pharmaceuticals, Inc. | 2 | $131 |
| Abbott | 5 | $125 |
| Pfizer | 6 | $125 |
| Sanofi-aventis U.S. LLC | 5 | $120 |
| Axsome Therapeutics, Inc. | 4 | $108 |
| Verity Pharmaceuticals Inc. | 4 | $107 |
| Dexcom, Inc. | 5 | $103 |
| Otsuka America Pharmaceutical, Inc. | 5 | $90 |
| Astellas Pharma US Inc | 5 | $77 |
| Viiv Healthcare Company | 4 | $65 |
| Antares Pharma, Inc. | 4 | $64 |
| Halozyme Inc | 4 | $63 |
| Idorsia Pharmaceuticals US Inc | 4 | $57 |
| Bayer | 3 | $52 |
| Biogen | 2 | $44 |
| Kyowa Kirin, Inc. | 2 | $36 |
| Avvisto Therapeutics, LLC | 2 | $32 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $28 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| Phadia US Inc. | 1 | $25 |
| Organon | 1 | $23 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Vivus LLC | 1 | $16 |
| Seqirus USA Inc | 1 | $15 |
| Exact Sciences | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,714 in reported general payments places this provider in the 95th percentile of 5,422 nurse practitioner providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 24 | $22,371 |
| FarxigaDapagliflozin Propanediol | 22 | $16,834 |
| MounjaroTirzepatide | 14 | $14,874 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $11,463 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 28 | $636 |
| Duloxetine Hcl | 20 | $512 |
| Fluticasone Propionate | 20 | $329 |
| Gabapentin | 25 | $314 |
| Atorvastatin Calcium | 51 | $305 |
| Metoprolol Succinate | 24 | $299 |
| Omeprazole | 19 | $220 |
| Amlodipine Besylate | 42 | $192 |
| Mirtazapine | 20 | $184 |
| Triamcinolone Acetonide | 15 | $176 |
| Levothyroxine Sodium | 19 | $147 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $501 | $22,37124 claims |
| AstraZenecaFarxiga | $173 | $16,83422 claims |
| Lilly USA, LLCMounjaro | $719 | $14,87414 claims |
| GSKTrelegy Ellipta | $286 | $11,46318 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,422 nurse practitioner providers in Texas.
Other nurse practitioner in Dallas
- Samantha OnealDallas$133K
- Tam TranDallas$37K
- Tobin SpeightDallas$35K
- Rachel TiuDallas$19K
- Cecilia DavisAustin$262K
- Melanie MorrisHouston$254K
- Stephanie BrownHarlingen$235K
- Brittney MisercolaKilleen$223K
- Roger ChapmanTyler$211K
- Kelly BrassilHouston$194K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.